Pretransplant sensitization against angiotensin II type 1 receptor is a riskfactor for acute rejection and graft loss
from American Journal of Transplantation
The angiotensin II type 1 receptor is an emerging target of functional non-HLA antibodies. We examined the potential of determining the degree of presensitization against AT1R as a risk factor for graft survival and acute rejection. The study included 599 kidney recipients between 1998 and 2007. Serum samples were analyzed in a blinded fashion for anti-AT1R antibodies using a quantitative solid-phase assay.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063